Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study
Journal of Pharmacy Practice · 2026
DOI: 10.1177/08971900251338904 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Pharmacy Practice, 2026. Verfasst von Robert Barrons und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wingate University School of Pharmacy, Wingate, NC, USA. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Drug Monitoring, Staphylococcal Infections. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
The 2020 consensus guidelines for drug monitoring of vancomycin recommended AUC-guided dosing to reduce acute kidney injury (AKI) and improve clinical outcomes in patients with serious methicillin-resistant Staphylococcus aureus (MRSA) infections previously managed with trough concentrations of 15–20 mg/L.
Objectives
To determine if AUC-guided dosing of vancomycin reduces AKI and improves clinical outcomes including non-invasive infections with S. aureus compared with trough-only dosing broadened to concentrations of 10–20 mg/L.
Methods
A retrospective, single-center, cohort study was conducted over 12 months comparing Bayesian software-guided AUC-dosing with trough-only dosing. Information collected included patient demographics, co-morbidities, concurrent nephrotoxins, assessment measures of drug exposure, and patient outcomes. Nominal data were analyzed using the chi-square test, and continuous data using the independent t test.
Results
Based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, the incidence of AKI was 7.65% and 6.06% ( P = 0.56), among 183 patients in the AUC-guided and 165 subjects in the trough-only groups, respectively. Individuals in the trough-only group were younger, had fewer co-morbidities and admissions to the ICU. A lower incidence of AKI findings among trough-only subjects was likely a result of the duration of therapy (mean of 4.2 days), mean trough concentrations
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wingate University School of Pharmacy, Wingate, NC, USA.
ORCID-Profile: Robert Barrons, Edward Chiyaka
Zitieren
APA
Barrons, R., & Chiyaka, E. (2026). Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251338904
Vancouver
Barrons R, Chiyaka E. Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900251338904
BibTeX
@article{Barrons2026,
author = {Barrons, Robert and Chiyaka, Edward},
title = {Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study},
journal = {Journal of Pharmacy Practice},
year = {2026},
doi = {10.1177/08971900251338904}
}
EUVIMED